StonvexLoading…
StonvexStonvexStonvexCore line items from BMNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-08-31 | Annual 2022 2022-08-31 | Annual 2021 2021-08-31 |
|---|---|---|---|---|
Revenue | $6.09M | $3.31M | $427.67K | $0.00 |
Operating Income | $444.21M | $-2.45M | $-1.71M | $-131.81K |
Net Income | $348.58M | $-3.29M | $-2.01M | $-154.24K |
EPS (Diluted) | $13.39 | $-1.32 | $-0.05 | $-0.02 |
Total Assets | $8.80B | $7.28M | $7.97M | $646.03K |
Total Liabilities | $102.26M | $3.20M | $570.00K | $285.48K |
Cash & Equivalents | $512.00M | $499.00K | $392.55K | $218.74K |
Free Cash Flow OCF − CapEx | $-5.21M | $-106.00K | $-4.40M | $-503.66K |
Shares Outstanding | 234.71K | 2.50K | 48.61M | 40.43M |